The Discounted Cash Flow (DCF) valuation of Avidity Biosciences Inc (RNA) is (107.12) USD. With the latest stock price at 30.35 USD, the upside of Avidity Biosciences Inc based on DCF is -453.0%.
Based on the latest price of 30.35 USD and our DCF valuation, Avidity Biosciences Inc (RNA) is a sell. selling Avidity stocks now will result in a potential gain of 453.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 7.8% | 6.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (499.51) - (61.29) | (107.12) |
| Upside | -1745.8% - -301.9% | -453.0% |